featured
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients With Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients With Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial
J Urol 2013 Sep 01;190(3)857-862, P Gontero, M Oderda, A Mehnert, A Gurioli, F Marson, I Lucca, M Rink, M Schmid, LA Kluth, G Pappagallo, F Sogni, F Sanguedolce, R Schiavina, G Martorana, SF Shariat, F ChunFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.